▲ 12:45 am — Schering-Plough just reported that it spent $550,000 on lobyists, in the second quarter of 2009. Added to the $610,000 it spent in the first quarter, all-in, Kenilworth has coughed up $1.16 million to lobbying efforts — and almost all of that, on health care reform.
▲ Merck reported it spent $1.5 million in Q2 2009, and $1.6 million in Q1 2009 — thus, between the two companies, they’ve spent $4.26 million — on health care reform messaging, and some patent law change positioning.
▲ Okay — We’ll begin here, in earnest, at about 7:20 am EDT. . . .
